Effectiveness of rifaximin in reducing central line-associated bloodstream infections in pediatric intestinal failure.

Xifaxan (rifaximin) - Alfa Wassermann, Bausch Health

http://www.ncbi.nlm.nih.gov/pubmed/42535493

Claire Konicek; Emma Johnson; Joseph Fishbein; Nathan Lamb; Ravi Jhaveri; Valeria Cohran

Aug 1, 2026